Which rheumatologic conditions have been linked to increased cardiovascular disease risk?

• A. Osteoarthritis and gout
• B. SLE and RA
• C. Fibromyalgia and eczema
• D. Psoriasis only

Answer: (B)

Chronic systemic inflammation from autoimmune rheumatic diseases drives accelerated atherosclerosis and raises cardiovascular risk. Systemic lupus erythematosus and rheumatoid arthritis are classic examples with robust, well-documented links to higher rates of heart attack, stroke, and other cardiovascular events. In SLE, immune complex deposition, antiphospholipid antibodies, lupus nephritis, and treatment-related factors like hypertension and dyslipidemia create a pro-thrombotic, pro-atherogenic environment. In RA, persistent inflammatory activity and elevated cytokines damage the endothelium and promote plaque formation, with risk that tracks with disease activity and duration.

Other options mix conditions with weaker or less consistent associations with cardiovascular risk (for example, osteoarthritis is largely degenerative rather than inflammatory; fibromyalgia is not a systemic inflammatory condition; eczema has less clear CV linkage). Psoriasis does have cardiovascular risk, but the combination of SLE and RA represents the strongest, more consistently observed link among rheumatologic diseases.

So, the pair that best reflects conditions clearly linked to increased cardiovascular risk is the one involving systemic lupus erythematosus and rheumatoid arthritis.